{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:38:08Z","timestamp":1789562288786,"version":"build-2803163510"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.clinre.2015.02.011","type":"journal-article","created":{"date-parts":[[2015,4,15]],"date-time":"2015-04-15T19:51:36Z","timestamp":1429127496000},"page":"296-306","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":93,"title":["Fenofibrate is effective adjunctive therapy in the treatment of primary biliary cirrhosis: A meta-analysis"],"prefix":"10.1016","volume":"39","author":[{"given":"Alla Y.","family":"Grigorian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houssam E.","family":"Mardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Corpechot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raoul","family":"Poupon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.clinre.2015.02.011_bib0160","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1053\/j.gastro.2005.12.029","article-title":"Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic acid","volume":"130","author":"Par\u00e9s","year":"2006","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.clinre.2015.02.011_bib0165","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.jhep.2011.02.031","article-title":"Early primary biliary cirrhosis: biochemical response to treatment and prediction of long-term outcome","volume":"55","author":"Corpechot","year":"2011","journal-title":"J Hepatol"},{"issue":"47","key":"10.1016\/j.clinre.2015.02.011_bib0170","doi-asserted-by":"crossref","first-page":"36703","DOI":"10.1074\/jbc.M004045200","article-title":"Induction of IkappaBalpha expression as a mechanism contributing to the anti-inflammatory activities of peroxisome proliferator-activated receptor-alpha activators","volume":"275","author":"Delerive","year":"2000","journal-title":"J Biol Chem"},{"issue":"46","key":"10.1016\/j.clinre.2015.02.011_bib0175","doi-asserted-by":"crossref","first-page":"35715","DOI":"10.1074\/jbc.M006577200","article-title":"Peroxisome proliferator-activated receptors and hepatic stellate cell activation","volume":"275","author":"Miyahara","year":"2000","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.clinre.2015.02.011_bib0180","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1002\/hep.23049","article-title":"Fenofibrate differentially regulates plasminogen activator inhibitor-1 gene expression via adenosine monophosphate-activated protein kinase-dependent induction of orphan nuclear receptor small heterodimer partner","volume":"50","author":"Chanda","year":"2009","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.clinre.2015.02.011_bib0185","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1002\/hep.26018","article-title":"Anticholestatic effects of bezafibrate in patients with primary biliary cirrhosis treated with ursodeoxycholic acid","volume":"57","author":"Honda","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2015.02.011_bib0190","first-page":"781348","article-title":"Effects of three different fibrates on intrahepatic cholestasis experimentally induced in rats","author":"El-Sisi","year":"2013","journal-title":"PPAR Res"},{"issue":"3","key":"10.1016\/j.clinre.2015.02.011_bib0195","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1002\/hep.26894","article-title":"Peroxisome proliferator-activated receptor (activates human multidrug resistance transporter 3\/ATP-binding cassette protein subfamily B4 transcription and increases rat biliary phosphatidylcholine secretion)","volume":"59","author":"Ghonem","year":"2014","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.clinre.2015.02.011_bib0200","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1159\/000324139","article-title":"Treatment of primary biliary cirrhosis with ursodeoxycholic acid, budesonide and fibrates","volume":"29","author":"Poupon","year":"2011","journal-title":"Dig Dis"},{"issue":"3","key":"10.1016\/j.clinre.2015.02.011_bib0205","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/MOG.0000000000000056","article-title":"Fibrate treatment for primary biliary cirrhosis","volume":"30","author":"Cuperus","year":"2014","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.clinre.2015.02.011_bib0210","first-page":"CD450091","article-title":"Bezafibrate for primary biliary cirrhosis","volume":"1","author":"Rudic","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clinre.2015.02.011_bib0215","series-title":"Assessment report for fenofibrate, bezafibrate, ciprofibrate and gemfibrozil containing medicinal product","year":"2014"},{"key":"10.1016\/j.clinre.2015.02.011_bib0220","series-title":"Development of a Quality Appraisal Tool for Case Series Studies Using a Modified Delphi Technique","author":"Moga","year":"2014"},{"key":"10.1016\/j.clinre.2015.02.011_bib0225","series-title":"Recommendations on testing for funnel plot, asymmetry., Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0.","year":"2014"},{"key":"10.1016\/j.clinre.2015.02.011_bib0230","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2288-5-13","article-title":"Estimating the mean and variance from the median, range, and the size of a sample","volume":"5","author":"Hozo","year":"2005","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.clinre.2015.02.011_bib0235","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1111\/j.1572-0241.2002.05944.x","article-title":"Fenofibrate treatment in patients with primary biliary cirrhosis","volume":"97","author":"Ohira","year":"2002","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.clinre.2015.02.011_bib0240","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1007\/s00535-004-1583-7","article-title":"Long-term fibrate treatment for PBC","volume":"40","author":"Nakamuta","year":"2005","journal-title":"J Gastroenterol"},{"issue":"10","key":"10.1016\/j.clinre.2015.02.011_bib0245","first-page":"350","article-title":"Effectiveness of fenofibrate in comparison to bezafibrate for patients with asymptomatic primary biliary cirrhosis","volume":"104","author":"Dohmen","year":"2013","journal-title":"Fukuoka Igaku Zasshi"},{"issue":"6","key":"10.1016\/j.clinre.2015.02.011_bib0250","doi-asserted-by":"crossref","first-page":"894","DOI":"10.3748\/wjg.v10.i6.894","article-title":"Fenofibrate for patients with asymptomatic primary biliary cirrhosis","volume":"10","author":"Dohmen","year":"2004","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clinre.2015.02.011_bib0255","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/hep.22670","article-title":"Comment on biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis","volume":"49","author":"Walker","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2015.02.011_bib0260","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-2036.2010.04512.x","article-title":"Pilot study: fenofibrate for patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid","volume":"33","author":"Levy","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clinre.2015.02.011_bib0265","doi-asserted-by":"crossref","first-page":"120","DOI":"10.2174\/1874192401004010120","article-title":"Fenofibrate in primary biliary cirrhosis: a pilot study","volume":"4","author":"Liberopoulos","year":"2010","journal-title":"Open Cardiovasc Med J"},{"issue":"4","key":"10.1016\/j.clinre.2015.02.011_bib0270","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1751-2980.2012.00574.x","article-title":"Efficacy of fenofibrate in Chinese patients with primary biliary cirrhosis partially responding to ursodeoxycholic acid therapy","volume":"13","author":"Han","year":"2012","journal-title":"J Dig Dis"},{"key":"10.1016\/j.clinre.2015.02.011_bib0275","unstructured":"Poupon R. Personal communication 4\/4\/2014."},{"issue":"6","key":"10.1016\/j.clinre.2015.02.011_bib0280","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1053\/j.gastro.2014.08.029","article-title":"Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up study","volume":"147","author":"Lammers","year":"2014","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.clinre.2015.02.011_bib0285","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1053\/j.gastro.2009.01.003","article-title":"Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid","volume":"136","author":"Kuiper","year":"2009","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.clinre.2015.02.011_bib0290","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/hep.22428","article-title":"Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis","volume":"48","author":"Corpechot","year":"2008","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.clinre.2015.02.011_bib0295","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.jhep.2009.11.027","article-title":"Primary biliary cirrhosis: a 2010 update","volume":"52","author":"Poupon","year":"2010","journal-title":"J Hepatol"},{"issue":"1\u00a0Suppl.","key":"10.1016\/j.clinre.2015.02.011_bib0300","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/S0168-8278(14)60134-3","article-title":"Effective stratification of hepatocellular carcinoma risk in primary biliary cirrhosis: results of a multi-centre international study","volume":"60","author":"Trivedi","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2015.02.011_bib0305","doi-asserted-by":"crossref","first-page":"S229","DOI":"10.1016\/S0168-8278(13)60941-1","article-title":"Who may have treatment benefits with fibrates in primary biliary cirrhosis: a Single Center Retrospective Observational Cohort Analysis","volume":"58","author":"Komori","year":"2013","journal-title":"J. Hepatol"},{"issue":"2","key":"10.1016\/j.clinre.2015.02.011_bib0310","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/liv.12290","article-title":"Bezafibrate normalizes alkaline phosphatase in primary biliary cirrhosis patients with incomplete response to ursodeoxycholic acid","volume":"34","author":"Lens","year":"2014","journal-title":"Liver Int"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740115000777?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740115000777?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:22:40Z","timestamp":1761895360000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740115000777"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S2210740115000777"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2015.02.011","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fenofibrate is effective adjunctive therapy in the treatment of primary biliary cirrhosis: A meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2015.02.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}